Senores Pharma Share: FY26 Results Toh Pehlan Trading Window Band, SEBI De Niyamanusar Eh Hai Vaddi Khabar!

OTHER
Whalesbook Corporate News Logo
AuthorMitali Deshmukh|Published at:
Senores Pharma Share: FY26 Results Toh Pehlan Trading Window Band, SEBI De Niyamanusar Eh Hai Vaddi Khabar!
Overview

Senores Pharmaceuticals Limited ne apne Directors, Promoters, te Designated Persons layyi trading window bandh karan da elan kitta hai. Eh window April 1, 2026 toun band ho jayegi te March 31, 2026 nu khatam hon wale quarter/fiscal year de audited financial results announce hon ton 48 ghante baad dobara khulegi. Eh kadam SEBI regulations anusar insider trading rokhan layyi hai.

Instant Stock Alerts on WhatsApp

Used by 10,000+ active investors

1

Add Stocks

Select the stocks you want to track in real time.

2

Get Alerts on WhatsApp

Receive instant updates directly to WhatsApp.

  • ✓Quarterly Results
  • ✓Concall Announcements
  • ✓New Orders & Big Deals
  • ✓Capex Announcements
  • ✓Bulk Deals
  • ✦And much more
Add StocksGet it on Google PlayDownload on the App Store

SEBI de Prohibition of Insider Trading (PIT) Regulations anusar, Senores Pharmaceuticals Limited ne 1 April, 2026 toun Directors, Promoters, te Designated Persons layyi apni trading window bandh karan da elan kitta hai. Eh rok apply rahegi jadh tak company March 31, 2026 nu khatam ho rahe fiscal year de audited financial results release nahi kardhi, usde 48 ghante baad tak. Es kadam da mukkh maksad insider trading nu rokna te market integrity bani rakhna hai.

Company Da Business Te Vistar

Senores Pharmaceuticals di global presence hai, jismein US, Canada, te UK jaisey regulated markets naal naal vikast shil mulkan vich v varti hai. Company generic drugs, Active Pharmaceutical Ingredients (APIs), te specialty pharmaceuticals da ik vishal spectrum develop te manufacture kardi hai. Apne Initial Public Offering (IPO) ton baad, Senores ne Dr. Reddy's Laboratories te Wockhardt jaisey companies ton drug approvals (ANDAs) di acquisition karke vistar kitta hai. Haal hi vich company ne mazboot sales growth dikhai hai, par profit margins mein utar-charhav dekhan nu mila hai.

Niveshakange Ki Vekhna Hai?

Investors hun Senores Pharmaceuticals ton Board Meeting di date da pata lagan di rai rakhde ne. Eh meeting March 31, 2026 nu khatam ho rahe quarter te fiscal year layyi audited financial results approve karan layyi zaroori hai. Inhan results da official release trading window de dobara khulan da signal dega.

Get stock alerts instantly on WhatsApp

Quarterly results, bulk deals, concall updates and major announcements delivered in real time.

Add Stocks
Disclaimer:This content is for educational and informational purposes only and does not constitute investment, financial, or trading advice, nor a recommendation to buy or sell any securities. Readers should consult a SEBI-registered advisor before making investment decisions, as markets involve risk and past performance does not guarantee future results. The publisher and authors accept no liability for any losses. Some content may be AI-generated and may contain errors; accuracy and completeness are not guaranteed. Views expressed do not reflect the publication’s editorial stance.